KATHLEEN K SCHOEMAKER

CIK 1207789 · last filed 2015-07-01

KATHLEEN K SCHOEMAKER is a corporate insider who has filed 58 SEC Form 4 insider transactions across 21 companies since 2007. The most recent filing, for GKOS, was dated Jul 1, 2015. Across all open-market trades the lifetime net is +$110.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $315.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$315.74M

Companies

21

Total Filings

58

Lifetime Open-Market Net

$110.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GKOS 10%+ Owner 876,083 $126.81 $111.10M $0 1 2015-07-01
LIFE 10%+ Owner 13,414 $15.61 $209.4K $0 1 2015-05-12
MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted 10%+ Owner 2,057,142 $0.55 $1.13M $20.15M 1 2014-08-07
Achaogen, Inc. (AKAO) Delisted 10%+ Owner 33,890 $0 1 2014-03-17
Dicerna Pharmaceuticals Inc (DRNA) Delisted 10%+ Owner 13,004 $38.22 $497.0K $0 1 2014-02-04
TNDM 10%+ Owner 3,189,058 $16.60 $52.94M $0 1 2013-11-19
VCYT 10%+ Owner 3,063,294 $47.33 $144.99M $0 1 2013-11-04
Evoke Pharma Inc (OMED) Delisted 10%+ Owner 5,250 $0 1 2013-09-30
Tobira Therapeutics, Inc. (RGDO) Delisted 10%+ Owner 4,614 $3.00M 1 2013-08-28
Ocera Therapeutics, Inc. (TZYM) Delisted 10%+ Owner 1,897,336 $8.00M 1 2013-07-16
ESPR 10%+ Owner 2,066,935 $3.15 $6.51M $4.00M 1 2013-07-02
Clovis Oncology, Inc. (CLVS) Delisted 10%+ Owner 79,422 $0.08 $6.4K $10.86M 2 2013-06-05
CADENCE PHARMACEUTICALS INC (CADX) Delisted 10%+ Owner 88,011 $13.44M 6 2013-03-21
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 159,896 $0 3 2013-01-18
Durata Therapeutics, Inc. (DRTX) Delisted 10%+ Owner 22,306 $7.06M 1 2012-07-24
Orexigen Therapeutics, Inc. (OREX) Delisted 10%+ Owner 59,701 $25.33M 15 2011-12-22
ZOGENIX, INC. (ZGNX) Delisted 10%+ Owner 169,251 $26.68 $4.52M $16.40M 2 2011-09-20
ALIMERA SCIENCES INC (ALIM) Delisted 10%+ Owner 18,864 $5.54 $104.5K $4.10M 2 2011-06-03
Paratek Pharmaceuticals, Inc. (NOVC) Delisted 10%+ Owner 3,115,960 -$514.6K 3 2009-01-30
Volcano Corp (VOLC) Delisted 10%+ Owner 1,898,427 -$985.0K 8 2008-07-18
SENORX INC (SENO) Delisted 10%+ Owner 24,665 $0 1 2007-04-03

Recent Filings

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-07-01 GKOS Conv (C) +6,132,581 $0 EDGAR
2015-05-12 LIFE Conv (C) +93,898 $0 EDGAR
2014-08-07 MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted Mixed +14,861,316 $20.15M EDGAR
2014-03-21 Disp (D) −10,442,531 -$146.20M
2014-03-17 Achaogen, Inc. (AKAO) Delisted Conv (C) +2,020,939 $0 EDGAR
2014-02-04 Dicerna Pharmaceuticals Inc (DRNA) Delisted Conv (C) +1,765,711 $0 EDGAR
2013-11-19 TNDM Mixed +3,243,448 $0 EDGAR
2013-11-04 VCYT Conv (C) +3,086,024 $0 EDGAR
2013-09-30 Evoke Pharma Inc (OMED) Delisted Conv (C) +1,133,333 $0 EDGAR
2013-08-28 Tobira Therapeutics, Inc. (RGDO) Delisted Mixed +2,550,109 $3.00M EDGAR
Showing 110 of 58
Page 1 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.